Healthcare & Biotech
Origami Therapeutics, Inc.
Oral drugs to halt neurodegeneration
Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our…
- Therapeutics
- Biotech
- Drug discovery
- Website
- origamitherapeutics.com
- Headquarters
- San Diego, CA, USA
- Team size
- 2-10 people
- Founded
- 2022
- Demo
- 20 min demo
Similar companies
Eris BiotechOur drugs engage the immune system to fight tumors
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.
Entelexo BiotherapeuticsCreating a New Class of Drugs to Address Incurable Autoimmune Diseases
Equator TherapeuticsWe are developing a drug to burn calories and increase metabolism…
Velorum TherapeuticsBreakthrough medicines unlocking the biology of heme
Sensible BiotechnologiesUnlocking the next generation of mRNA medicines
Serinus BiosciencesCombinations therapy by rational design
HepatxReplacing organ transplant with an infusion